Skip to content

Anxiety: all studies

Page 294 of 773: studies 2,931 to 2,940 of 7,721, newest first. Back to the anxiety overview

Research

Altered Beliefs, Attitudes, and Behaviors Following Near-Death Experiences

Journal of Humanistic Psychology July 1, 1998 Gary Groth‐marnat, Roger Summers 66 citations

This study investigated the extent and types of altered beliefs, attitudes, and values of 53 subjects who reported having had a neardeath experience (NDE). A control group was composed of 27 individuals who reported having had similar life-threatening incidents but without a corresponding NDE. In addition, 45 significant others in the lives of the participants in these groups rated the extent...

DOI: 10.1177/00221678980383005 (opens in new tab) Afterlife Paranormal Phenomenon Death anxiety +4

LSD-Like Panic From Risperidone in Post-LSD Visual Disorder

Journal of Clinical Psychopharmacology June 1, 1996 Henry David Abraham, Anitra Mamen 50 citations

Risperidone, a novel antipsychotic agent, is an antagonist of postsynaptic serotonin-2 and dopamine D2 receptors. In certain individuals, the hallucinogenic drug lysergic acid diethylamide (LSD) is associated with apparently lifelong continuous visual disturbances, characterized in DSM-IV as hallucinogen-persisting perception disorder (HPPD). Because the hallucinogenic mechanism of LSD is known...

Persistent Palinopsia Following Ingestion of Lysergic Acid Diethylamide (LSD)

Archives of Ophthalmology 1996 Aki Kawasaki 64 citations

We have described three patients in whom persistent palinopsia developed following ingestion of LSD. Clinicians should inquire about past LSD use in all patients who initially have seemingly spontaneous, isolated palinopsia. Recognition of this distinctive clinical syndrome associated with LSD use might avoid unnecessary anxiety and excessive diagnostic tests for patients with this disorder.

Meditation as an adjunct to a happiness enhancement program.

Journal of Clinical Psychology March 1, 1995 W P Smith, W C Compton, W B West

This study investigated the impact that meditation has on Fordyce's (1977, 1983) Personal Happiness Enhancement Program (PHEP). Experimental subjects were divided into two groups, both of which received instruction on the PHEP. Subjects in one experimental group were taught a meditation exercise in addition to the PHEP. A control group received no instruction. The Happiness Measure, Psychap...

A preliminary study of opening-up meditation college adjustment, and self-actualization.

Psychological Reports August 1, 1994 J Tloczynski

The effects of opening-up meditation on college adjustment and self-actualization were examined with 45 subjects who were divided into groups for opening-up meditation, relaxation, and control using scores on the Anxiety Scale of the College Adjustment Scales. Subjects also completed the Personal Orientation Inventory. 1 hr. of training for the meditation and relaxation groups was given and 20...

DOI: 10.2466/pr0.1994.75.1.449 (opens in new tab) Anxiety Humans Adaptation, psychological Self concept +6

Reduced death threat in near-death experiencers

Death Studies November 1, 1992 Bruce Greyson 58 citations

Abstract Near-death experiences (NDEs), profound mystical or transcendental experiences occurring on the threshold of death, have been reported to reduce fear of death and death anxiety. This study compared responses to the Threat Index, a widely used measure of the threat implied by one's personal death, of (a) 135 near-death experiences, (b) 43 individuals who had come close to death but not...

DOI: 10.1080/07481189208252596 (opens in new tab) Death anxiety Fear of death Cause of death Clinical psychology +2

Poisoning by hallucinogenic mushroom Hikageshibiretake (Psilocybe argentipes K. Yokoyama) indigenous to Japan.

The Tohoku Journal of Experimental Medicine 1986 Morihiro Musha, Atsushi Ishii, Fumio Tanaka et al. 15 citations

Five cases of poisoning by indigenous mushroom Hikageshibiretake (Psilocybe argentipes) are reported. As this mushroom contains psilocybin, in general, clinical features were similar to those seen by pure psilocybin. Acute toxic stuporous state with complete amnesia in the culminating period occurred in one case, psychedelic state with dreamy consciousness in one case and psychotic adverse...

Coping effectiveness and dreams as a function of personality and dream recall.

Journal of Clinical Psychology April 1, 1978 G L Gerber

Investigated the proposition that effectiveness of coping with daytime and dream stress would be influenced by personality style, as defined by the Repression-Sensitization scale (R-S), and by dreaming style, as defined by frequent (F) or infrequent (I) questionnaire dream recall. The relationship between R-S and F-I dream recall also was explored. Ss kept dream diaries for 30 consecutive days....

MDA-ASSISTED PSYCHOTHERAPY WITH NEUROTIC OUTPATIENTS

The Journal of Nervous and Mental Disease October 1, 1976 Richard Yensen, Francesco B. Di Leo, John Rhead et al. 51 citations

Ten neurotic patients (five males and five females) were treated over a period of 2 to 6 months (mean, 4.1) as outpatients. The study allowed for a maximum of 75 hours of psychotherapy (mean, 51.55 hours). During the course of treatment, two to four (mean, 3.5) administrations of MDA (3,4-methylenedioxyamphetamine) were employed as adjunctive aids in an effort to enhance the psychotherapeutic...

DOI: 10.1097/00005053-197610000-00002 (opens in new tab) Anxiety Neuroticism Rating scale Depression economics +5

BEHAVIOR THERAPY TO EXTINGUISH SPONTANEOUS RECURRENCES OF LSD EFFECTS

The Journal of Nervous and Mental Disease April 1, 1973 Robert E. Matefy 14 citations

Systematic desensitization in conjunction with other behavior techniques was utilized to treat a client who for 5 months was experiencing spontaneous recurrences of LSD effects. Besides the elimination of the target symptoms (flashback effects), additional desired changes occurred on both cognitive-affective and behavioral levels. A theoretical explanation of LSD flashback effects based on the...

DOI: 10.1097/00005053-197304000-00002 (opens in new tab) Anxiety Flashback Desensitization medicine Systematic desensitization +5